Research Overview: Winstrol Tablets Odin Pharma 50 Tablets Odin Pharmaceuticals
Stanozolol is a synthetic anabolic steroid derived from dihydrotestosterone, extensively investigated in laboratory environments for its unique molecular characteristics. Researchers at Stroid UK Shop examine this compound’s distinctive properties in cellular assays and receptor binding studies. Unlike many androgenic compounds, stanozolol demonstrates modified structural features that make it valuable for investigating steroid-receptor interactions. Laboratory investigations focus on its synthetic modifications to the traditional steroid backbone, which alter its binding affinity and cellular uptake mechanisms.
Molecular Investigation Parameters
Research teams study stanozolol’s modified A-ring structure and its impact on androgenic receptor selectivity in controlled laboratory conditions. The compound’s structural alterations from its parent molecule provide researchers with opportunities to examine how synthetic modifications influence biological activity patterns. Scientists investigating stanozolol formulations analyse its interaction with various cellular protein systems and enzymatic pathways. Comparative studies with other synthetic androgens help researchers understand structure-activity relationships in steroid biochemistry. The tablet formulation allows for precise dosing in laboratory protocols examining oral bioavailability and metabolic pathways.
Advanced Research Applications
Contemporary laboratory investigations utilise stanozolol in studies examining androgenic signalling cascades and protein synthesis pathways in cellular models. Researchers analyse its effects on gene expression patterns and transcriptional regulation mechanisms in controlled experimental environments. The compound serves as a valuable tool for investigating steroid metabolism, particularly hepatic processing pathways and enzymatic breakdown products. Scientists studying selective androgen modulators often use stanozolol as a comparative reference compound due to its well-characterised properties. Additionally, investigations into muscle protein synthesis mechanisms and peptide interactions frequently incorporate stanozolol in experimental protocols.
Technical Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | 17α-Methyl-5α-androstano[3,2-c]pyrazol-17β-ol |
| Molecular Formula | C₂₁H₃₂N₂O |
| Molecular Weight | 328.49 g/mol |
| CAS Registry | 10418-03-8 |
| Tablet Strength | 50mg per tablet |
| Package Count | 50 tablets |
| Storage Requirements | Room temperature, dry conditions |
| Solubility | Practically insoluble in water |
Research Compliance Notice: This stanozolol formulation is supplied exclusively for in-vitro research applications and laboratory investigations. This product is not intended for human consumption, therapeutic applications, or any clinical purposes. Researchers must ensure compliance with institutional guidelines and applicable research regulations when conducting studies with this compound.
